CAUTIONFEDGLP-1 Compounding2025-07-02

FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 …

FDA recalls GLP-1 product due to sterility concerns.

What to do

Free

Enter your email to unlock “What to do” on every alert — and get the weekly Brief. No charge.

Want it filtered to YOUR states + real-time alerts? Become a member →

FDA Enforcement · primary source ↗

Related alerts

Monitoring, not legal advice.